Persistent asymptomatic(PA)SARS-CoV-2 infections have been identified.The immune responses in these patients are unclear,and the development of effective treatments for these patients is needed.Here,we report a cohort...Persistent asymptomatic(PA)SARS-CoV-2 infections have been identified.The immune responses in these patients are unclear,and the development of effective treatments for these patients is needed.Here,we report a cohort of 23 PA cases carrying viral RNA for up to 191 days.PA cases displayed low levels of inflammatory and interferon response,weak antibody response,diminished circulating follicular helper T cells(cTfh),and inadequate specific CD4+and CD8+T-cell responses during infection,which is distinct from symptomatic infections and resembling impaired immune activation.Administration of a single dose of Ad5-nCoV vaccine to 10 of these PA cases elicited rapid and robust antibody responses as well as coordinated B-cell and cTfh responses,resulting in successful viral clearance.Vaccine-induced antibodies were able to neutralize various variants of concern and persisted for over 6 months,indicating long-term protection.Therefore,our study provides an insight into the immune status of PA infections and highlights vaccination as a potential treatment for prolonged SARS-CoV-2 infections.展开更多
基金the National Key R&D Program of China(2021YFC2302004 and 2021YFC2301102)National Natural Science Foundation of China(82172240,82101836,81901623 and 82201933)+6 种基金China National Postdoctoral Program for Innovative Talents(BX2021087),China Postdoctoral Science Foundation(2021M690787 and 2022M710892)Guangdong Basic and Applied Basic Research Foundation(2021B1515130005 and 2022B1515020059)Guangdong Medical Technology Research Foundation(B2022233)Guangzhou Science and Technology Planning Program Municipal School/Institute-Joint Funded Program(202102010143)PhD Startup Foundation from Guangzhou Women and Children’s Medical Center(2018-2020)State Key Laboratory of Respiratory Diseases Funded Program(SKLRD-Z-202330)Zhong Nanshan Medical Foundation of Guangdong Province(ZNSA-202001,ZNSXS-2020012,ZNSA-2020013 and ZNSXS-20220015).
文摘Persistent asymptomatic(PA)SARS-CoV-2 infections have been identified.The immune responses in these patients are unclear,and the development of effective treatments for these patients is needed.Here,we report a cohort of 23 PA cases carrying viral RNA for up to 191 days.PA cases displayed low levels of inflammatory and interferon response,weak antibody response,diminished circulating follicular helper T cells(cTfh),and inadequate specific CD4+and CD8+T-cell responses during infection,which is distinct from symptomatic infections and resembling impaired immune activation.Administration of a single dose of Ad5-nCoV vaccine to 10 of these PA cases elicited rapid and robust antibody responses as well as coordinated B-cell and cTfh responses,resulting in successful viral clearance.Vaccine-induced antibodies were able to neutralize various variants of concern and persisted for over 6 months,indicating long-term protection.Therefore,our study provides an insight into the immune status of PA infections and highlights vaccination as a potential treatment for prolonged SARS-CoV-2 infections.
